Market Analysis and Insights: Global Blood Glucose Monitoring Market
The research report studies the Blood Glucose Monitoring market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Blood Glucose Monitoring market size is projected to reach US$ 10610 million by 2027, from US$ 7877 million in 2020, at a CAGR of 3.9% during 2021-2027.
Global Blood Glucose Monitoring Scope and Segment
The global Blood Glucose Monitoring market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Blood Glucose Monitoring market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
by Type, the market is primarily split into
Single Point Blood Glucose Meters
Continuous Glucose Monitoring Systems
by Application, this report covers the following segments
Hospitals Diagnostic Centers
Home Settings
Clinics
Global Blood Glucose Monitoring market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The Blood Glucose Monitoring key players in this market include:
Abbott Laboratories
ARKRAY, Inc.
Bayer AG
Dexcom, Inc.
F. Hoffmann-La Roche Ltd
Johnson & Johnson
Medtronic plc
Nipro Diagnostics, Inc.
Terumo Medical Corporation
The research report studies the Blood Glucose Monitoring market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Blood Glucose Monitoring market size is projected to reach US$ 10610 million by 2027, from US$ 7877 million in 2020, at a CAGR of 3.9% during 2021-2027.
Global Blood Glucose Monitoring Scope and Segment
The global Blood Glucose Monitoring market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Blood Glucose Monitoring market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
by Type, the market is primarily split into
Single Point Blood Glucose Meters
Continuous Glucose Monitoring Systems
by Application, this report covers the following segments
Hospitals Diagnostic Centers
Home Settings
Clinics
Global Blood Glucose Monitoring market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The Blood Glucose Monitoring key players in this market include:
Abbott Laboratories
ARKRAY, Inc.
Bayer AG
Dexcom, Inc.
F. Hoffmann-La Roche Ltd
Johnson & Johnson
Medtronic plc
Nipro Diagnostics, Inc.
Terumo Medical Corporation
1 Market Overview of Blood Glucose Monitoring
1.1 Blood Glucose Monitoring Market Overview
1.1.1 Blood Glucose Monitoring Product Scope
1.1.2 Blood Glucose Monitoring Market Status and Outlook
1.2 Global Blood Glucose Monitoring Market Size Overview by Region 2016 VS 2021VS 2027
1.3 Global Blood Glucose Monitoring Market Size by Region (2016-2027)
1.4 Global Blood Glucose Monitoring Historic Market Size by Region (2016-2021)
1.5 Global Blood Glucose Monitoring Market Size Forecast by Region (2022-2027)
1.6 Key Regions, Blood Glucose Monitoring Market Size (2016-2027)
1.6.1 North America Blood Glucose Monitoring Market Size (2016-2027)
1.6.2 Europe Blood Glucose Monitoring Market Size (2016-2027)
1.6.3 Asia-Pacific Blood Glucose Monitoring Market Size (2016-2027)
1.6.4 Latin America Blood Glucose Monitoring Market Size (2016-2027)
1.6.5 Middle East & Africa Blood Glucose Monitoring Market Size (2016-2027)
2 Blood Glucose Monitoring Market Overview by Type
2.1 Global Blood Glucose Monitoring Market Size by Type: 2016 VS 2021 VS 2027
2.2 Global Blood Glucose Monitoring Historic Market Size by Type (2016-2021)
2.3 Global Blood Glucose Monitoring Forecasted Market Size by Type (2022-2027)
2.4 Single Point Blood Glucose Meters
2.5 Continuous Glucose Monitoring Systems
3 Blood Glucose Monitoring Market Overview by Application
3.1 Global Blood Glucose Monitoring Market Size by Application: 2016 VS 2021 VS 2027
3.2 Global Blood Glucose Monitoring Historic Market Size by Application (2016-2021)
3.3 Global Blood Glucose Monitoring Forecasted Market Size by Application (2022-2027)
3.4 Hospitals Diagnostic Centers
3.5 Home Settings
3.6 Clinics
4 Blood Glucose Monitoring Competition Analysis by Players
4.1 Global Blood Glucose Monitoring Market Size by Players (2016-2021)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Blood Glucose Monitoring as of 2020)
4.3 Date of Key Players Enter into Blood Glucose Monitoring Market
4.4 Global Top Players Blood Glucose Monitoring Headquarters and Area Served
4.5 Key Players Blood Glucose Monitoring Product Solution and Service
4.6 Competitive Status
4.6.1 Blood Glucose Monitoring Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories Blood Glucose Monitoring Products, Services and Solutions
5.1.4 Abbott Laboratories Blood Glucose Monitoring Revenue (US$ Million) & (2016-2021)
5.1.5 Abbott Laboratories Recent Developments
5.2 ARKRAY, Inc.
5.2.1 ARKRAY, Inc. Profile
5.2.2 ARKRAY, Inc. Main Business
5.2.3 ARKRAY, Inc. Blood Glucose Monitoring Products, Services and Solutions
5.2.4 ARKRAY, Inc. Blood Glucose Monitoring Revenue (US$ Million) & (2016-2021)
5.2.5 ARKRAY, Inc. Recent Developments
5.3 Bayer AG
5.3.1 Bayer AG Profile
5.3.2 Bayer AG Main Business
5.3.3 Bayer AG Blood Glucose Monitoring Products, Services and Solutions
5.3.4 Bayer AG Blood Glucose Monitoring Revenue (US$ Million) & (2016-2021)
5.3.5 Dexcom, Inc. Recent Developments
5.4 Dexcom, Inc.
5.4.1 Dexcom, Inc. Profile
5.4.2 Dexcom, Inc. Main Business
5.4.3 Dexcom, Inc. Blood Glucose Monitoring Products, Services and Solutions
5.4.4 Dexcom, Inc. Blood Glucose Monitoring Revenue (US$ Million) & (2016-2021)
5.4.5 Dexcom, Inc. Recent Developments
5.5 F. Hoffmann-La Roche Ltd
5.5.1 F. Hoffmann-La Roche Ltd Profile
5.5.2 F. Hoffmann-La Roche Ltd Main Business
5.5.3 F. Hoffmann-La Roche Ltd Blood Glucose Monitoring Products, Services and Solutions
5.5.4 F. Hoffmann-La Roche Ltd Blood Glucose Monitoring Revenue (US$ Million) & (2016-2021)
5.5.5 F. Hoffmann-La Roche Ltd Recent Developments
5.6 Johnson & Johnson
5.6.1 Johnson & Johnson Profile
5.6.2 Johnson & Johnson Main Business
5.6.3 Johnson & Johnson Blood Glucose Monitoring Products, Services and Solutions
5.6.4 Johnson & Johnson Blood Glucose Monitoring Revenue (US$ Million) & (2016-2021)
5.6.5 Johnson & Johnson Recent Developments
5.7 Medtronic plc
5.7.1 Medtronic plc Profile
5.7.2 Medtronic plc Main Business
5.7.3 Medtronic plc Blood Glucose Monitoring Products, Services and Solutions
5.7.4 Medtronic plc Blood Glucose Monitoring Revenue (US$ Million) & (2016-2021)
5.7.5 Medtronic plc Recent Developments
5.8 Nipro Diagnostics, Inc.
5.8.1 Nipro Diagnostics, Inc. Profile
5.8.2 Nipro Diagnostics, Inc. Main Business
5.8.3 Nipro Diagnostics, Inc. Blood Glucose Monitoring Products, Services and Solutions
5.8.4 Nipro Diagnostics, Inc. Blood Glucose Monitoring Revenue (US$ Million) & (2016-2021)
5.8.5 Nipro Diagnostics, Inc. Recent Developments
5.9 Terumo Medical Corporation
5.9.1 Terumo Medical Corporation Profile
5.9.2 Terumo Medical Corporation Main Business
5.9.3 Terumo Medical Corporation Blood Glucose Monitoring Products, Services and Solutions
5.9.4 Terumo Medical Corporation Blood Glucose Monitoring Revenue (US$ Million) & (2016-2021)
5.9.5 Terumo Medical Corporation Recent Developments
6 North America
6.1 North America Blood Glucose Monitoring Market Size by Country (2016-2027)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Blood Glucose Monitoring Market Size by Country (2016-2027)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Blood Glucose Monitoring Market Size by Region (2016-2027)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Blood Glucose Monitoring Market Size by Country (2016-2027)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Blood Glucose Monitoring Market Size by Country (2016-2027)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Blood Glucose Monitoring Market Dynamics
11.1 Blood Glucose Monitoring Industry Trends
11.2 Blood Glucose Monitoring Market Drivers
11.3 Blood Glucose Monitoring Market Challenges
11.4 Blood Glucose Monitoring Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
1.1 Blood Glucose Monitoring Market Overview
1.1.1 Blood Glucose Monitoring Product Scope
1.1.2 Blood Glucose Monitoring Market Status and Outlook
1.2 Global Blood Glucose Monitoring Market Size Overview by Region 2016 VS 2021VS 2027
1.3 Global Blood Glucose Monitoring Market Size by Region (2016-2027)
1.4 Global Blood Glucose Monitoring Historic Market Size by Region (2016-2021)
1.5 Global Blood Glucose Monitoring Market Size Forecast by Region (2022-2027)
1.6 Key Regions, Blood Glucose Monitoring Market Size (2016-2027)
1.6.1 North America Blood Glucose Monitoring Market Size (2016-2027)
1.6.2 Europe Blood Glucose Monitoring Market Size (2016-2027)
1.6.3 Asia-Pacific Blood Glucose Monitoring Market Size (2016-2027)
1.6.4 Latin America Blood Glucose Monitoring Market Size (2016-2027)
1.6.5 Middle East & Africa Blood Glucose Monitoring Market Size (2016-2027)
2 Blood Glucose Monitoring Market Overview by Type
2.1 Global Blood Glucose Monitoring Market Size by Type: 2016 VS 2021 VS 2027
2.2 Global Blood Glucose Monitoring Historic Market Size by Type (2016-2021)
2.3 Global Blood Glucose Monitoring Forecasted Market Size by Type (2022-2027)
2.4 Single Point Blood Glucose Meters
2.5 Continuous Glucose Monitoring Systems
3 Blood Glucose Monitoring Market Overview by Application
3.1 Global Blood Glucose Monitoring Market Size by Application: 2016 VS 2021 VS 2027
3.2 Global Blood Glucose Monitoring Historic Market Size by Application (2016-2021)
3.3 Global Blood Glucose Monitoring Forecasted Market Size by Application (2022-2027)
3.4 Hospitals Diagnostic Centers
3.5 Home Settings
3.6 Clinics
4 Blood Glucose Monitoring Competition Analysis by Players
4.1 Global Blood Glucose Monitoring Market Size by Players (2016-2021)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Blood Glucose Monitoring as of 2020)
4.3 Date of Key Players Enter into Blood Glucose Monitoring Market
4.4 Global Top Players Blood Glucose Monitoring Headquarters and Area Served
4.5 Key Players Blood Glucose Monitoring Product Solution and Service
4.6 Competitive Status
4.6.1 Blood Glucose Monitoring Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories Blood Glucose Monitoring Products, Services and Solutions
5.1.4 Abbott Laboratories Blood Glucose Monitoring Revenue (US$ Million) & (2016-2021)
5.1.5 Abbott Laboratories Recent Developments
5.2 ARKRAY, Inc.
5.2.1 ARKRAY, Inc. Profile
5.2.2 ARKRAY, Inc. Main Business
5.2.3 ARKRAY, Inc. Blood Glucose Monitoring Products, Services and Solutions
5.2.4 ARKRAY, Inc. Blood Glucose Monitoring Revenue (US$ Million) & (2016-2021)
5.2.5 ARKRAY, Inc. Recent Developments
5.3 Bayer AG
5.3.1 Bayer AG Profile
5.3.2 Bayer AG Main Business
5.3.3 Bayer AG Blood Glucose Monitoring Products, Services and Solutions
5.3.4 Bayer AG Blood Glucose Monitoring Revenue (US$ Million) & (2016-2021)
5.3.5 Dexcom, Inc. Recent Developments
5.4 Dexcom, Inc.
5.4.1 Dexcom, Inc. Profile
5.4.2 Dexcom, Inc. Main Business
5.4.3 Dexcom, Inc. Blood Glucose Monitoring Products, Services and Solutions
5.4.4 Dexcom, Inc. Blood Glucose Monitoring Revenue (US$ Million) & (2016-2021)
5.4.5 Dexcom, Inc. Recent Developments
5.5 F. Hoffmann-La Roche Ltd
5.5.1 F. Hoffmann-La Roche Ltd Profile
5.5.2 F. Hoffmann-La Roche Ltd Main Business
5.5.3 F. Hoffmann-La Roche Ltd Blood Glucose Monitoring Products, Services and Solutions
5.5.4 F. Hoffmann-La Roche Ltd Blood Glucose Monitoring Revenue (US$ Million) & (2016-2021)
5.5.5 F. Hoffmann-La Roche Ltd Recent Developments
5.6 Johnson & Johnson
5.6.1 Johnson & Johnson Profile
5.6.2 Johnson & Johnson Main Business
5.6.3 Johnson & Johnson Blood Glucose Monitoring Products, Services and Solutions
5.6.4 Johnson & Johnson Blood Glucose Monitoring Revenue (US$ Million) & (2016-2021)
5.6.5 Johnson & Johnson Recent Developments
5.7 Medtronic plc
5.7.1 Medtronic plc Profile
5.7.2 Medtronic plc Main Business
5.7.3 Medtronic plc Blood Glucose Monitoring Products, Services and Solutions
5.7.4 Medtronic plc Blood Glucose Monitoring Revenue (US$ Million) & (2016-2021)
5.7.5 Medtronic plc Recent Developments
5.8 Nipro Diagnostics, Inc.
5.8.1 Nipro Diagnostics, Inc. Profile
5.8.2 Nipro Diagnostics, Inc. Main Business
5.8.3 Nipro Diagnostics, Inc. Blood Glucose Monitoring Products, Services and Solutions
5.8.4 Nipro Diagnostics, Inc. Blood Glucose Monitoring Revenue (US$ Million) & (2016-2021)
5.8.5 Nipro Diagnostics, Inc. Recent Developments
5.9 Terumo Medical Corporation
5.9.1 Terumo Medical Corporation Profile
5.9.2 Terumo Medical Corporation Main Business
5.9.3 Terumo Medical Corporation Blood Glucose Monitoring Products, Services and Solutions
5.9.4 Terumo Medical Corporation Blood Glucose Monitoring Revenue (US$ Million) & (2016-2021)
5.9.5 Terumo Medical Corporation Recent Developments
6 North America
6.1 North America Blood Glucose Monitoring Market Size by Country (2016-2027)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Blood Glucose Monitoring Market Size by Country (2016-2027)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Blood Glucose Monitoring Market Size by Region (2016-2027)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Blood Glucose Monitoring Market Size by Country (2016-2027)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Blood Glucose Monitoring Market Size by Country (2016-2027)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Blood Glucose Monitoring Market Dynamics
11.1 Blood Glucose Monitoring Industry Trends
11.2 Blood Glucose Monitoring Market Drivers
11.3 Blood Glucose Monitoring Market Challenges
11.4 Blood Glucose Monitoring Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
